Buspirone Hydrochloride Tablet
Product Images NDC 70518-4317

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 70518-4317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is information for busPIRone HCI 7.5 mg tablets, with a quantity of 30 tablets. The medication is prescription only, and the NDC number is 70518-4317-00. The manufacturer is Aurobindo Pharma located in Hyderabad, India. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). It is advised to keep the medication out of the reach of children. Further directions for use can be found in the package insert.*
FDA Label Image

Patient Instruction Sheet (Buspirone Fig1)

Patient Instruction Sheet (Buspirone Fig1)
This text provides instructions on how to divide tablets for different prescribed dosages by a doctor. It includes information on splitting tablets for dosages such as 20 mg, 15 mg, 10 mg, and 5 mg, indicating the tablet portion required for each specific dosage.*
FDA Label Image

Figure (Buspirone Fig2)

FDA Label Image

Chemical Structure (Buspirone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.